Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMY-101 in adults with gingivitis
NCT03694444Phase 2Completed
- Sponsor
- Amyndas Pharmaceuticals
- Start
- Jul 2019
- Primary completion
- Aug 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of AMY-101 in gingivitis, sponsored by Amyndas Pharmaceuticals. Started Jul 2019; status: completed.
02
Drugs
AMY-101
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT03694444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03694444.